Pyridazine

Pyridazine

SCHEMBL29178552

CCCCc1c[nH]nn1.c1ccnnc1

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.34
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
IDO1 P14902 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
GABRB2 P47870 1/20 0.32
GABRA4 P48169 1/20 0.32
GABRE P78334 1/20 0.32
GABRA6 Q16445 1/20 0.32
GABRG1 Q8N1C3 1/20 0.32
GABRG3 Q99928 1/20 0.32
GABRQ Q9UN88 1/20 0.32
CYP19A1 P11511 3/20 0.31
NOS2 P35228 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrimidine SCHEMBL28730173 0.85 TDP1 (0.34) KCNH2GABRPGABRDGABRA1IDO1
SCHEMBL628308 0.83 KCNH2 (0.44) KCNH2CYP19A1L3MBTL1HRH3
SCHEMBL16196855 0.82 KCNH2 (0.47) KCNH2CYP19A1HRH3
SCHEMBL245886 0.82 KCNH2 (0.47) KCNH2CYP19A1HRH3
SCHEMBL243705 0.82 KCNH2 (0.47) KCNH2CYP19A1HRH3
SCHEMBL5603669 0.82 KCNH2 (0.47) KCNH2CYP19A1HRH3
SCHEMBL5600895 0.82 KCNH2 (0.47) KCNH2CYP19A1HRH3
SCHEMBL245127 0.82 KCNH2 (0.47) KCNH2CYP19A1HRH3
SCHEMBL5601502 0.82 KCNH2 (0.47) KCNH2CYP19A1HRH3
SCHEMBL5023555 0.82 KCNH2 (0.47) KCNH2CYP19A1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114302886-B Triazolopyridazine derivative, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2024-03-22 CN disclosed